Table 2.
Demographic and clinical characteristics of the subjects
| AD patients | Controls | |
|---|---|---|
| [18F]flortaucipir | ||
| n | 10 | 9 |
| Age (years ± SD) | 64.4 ± 7.2 | 69.8 ± 4.5 |
| MMSE ± SD | 23.9 ± 3.1 | 29.1 ± 0.6 |
| Weight (kg ± SD) | 76.3 ± 10.7 | 82.4 ± 13.6 |
| Length (cm ± SD) | 175.4 ± 7.5 | 180.0 ± 7.6 |
| [18F]florbetapir | ||
| n | 8 | 6 |
| Age (years ± SD) | 65.6 ± 5.7 | 64.8 ± 3.3 |
| MMSE ± SD | 21.3 ± 2.3 | 29.8 ± 0.4 |
| Weight (kg ± SD) | 83.6 ± 12.4 | 86.2 ± 16.0 |
| Length (cm ± SD) | 180.3 ± 7.2 | 176.0 ± 14.6 |